372824005: Polymyxin B (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with antibacterial mechanism of action (substance)\Polymyxin\Polymyxin B

\Drug or medicament (substance)\Anti-infective agent (substance)\Substance with antibacterial mechanism of action (substance)\Polymyxin\Polymyxin B

\Substance categorised by structure\Chemical\Chemical categorized by structure\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative\Substituted amide (substance)\Peptide\Cyclic peptide\Polymyxin\Polymyxin B

\Organic compound\Organic cyclic compound\Polycyclic compound\Cyclic peptide\Polymyxin\Polymyxin B
\Organic compound\Organic nitrogen compound\Amide and/or amide derivative\Substituted amide (substance)\Peptide\Cyclic peptide\Polymyxin\Polymyxin B

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Polymyxin B	Is a	Polymyxin	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Polymyxin B	Is a	antibiotique cutané	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Polymyxin B	Is a	allergène médicamenteux	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Polymyxin B	Has disposition	Antibacterial (disposition)	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Polymyxin B sulfate ophthalmic preparation (substance)	Is a	False	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)
Polymyxin B sulfate (substance)	Is a	False	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)
Polymyxin B sulphate otic agent	Is a	False	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)
Sulphomyxin	Is a	False	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)
Polymixin-B measurement	Component	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Polymyxin B adverse reaction	Causative agent (attribute)	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Allergy to polymyxin B	Causative agent (attribute)	False	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)
Polymyxin B eye ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)
Polymyxin B eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)
Polymyxin B sulfate+trimethoprim eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)
Polymyxin B sulfate+bacitracin zinc eye ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)
Polymyxin B sulfate+trimethoprim eye ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)
Polymyxin B sulfate+bacitracin zinc 10,000u/500u ophthalmic ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)
Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/ns/10000unt ointment (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)
Dexamethasone + neomycin sulfate + polymyxin b sulphate 0.1%wv/ns/10000unt suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)
Gramicidin + neomycin sulfate + polymyxin b sulphate 0.025mg/1.75mg/10000unt solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydrocortisone + neomycin sulfate + polymyxin b sulphate 10mg/5mg/1.6mg suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydrocortisone+neomycin sulfate+polymyxin b sulphate 10mg/5ns/10000unt suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydrocortisone + neomycin sulfate + polymyxin b sulphate 10mg/7.5mg/10000unt suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydrocortisone + neomycin sulfate + polymyxin b sulphate 10mg/7.5mg/1000unt solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydrocortisone + polymyxin b 5mg/10000unt drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydrocortisone acetate + neomycin sulfate + polymyxin b sulfate 5mg/3.5mg/10000unit cream	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)
Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)
Polymyxin b sulfate + trimethoprim sulfate 10000unt/ns solution (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing polymyxin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Lidocaine- and neomycin- and polymyxin B-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing neomycin and polymyxin B and pramocaine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Bacitracin- and neomycin- and polymyxin B- and pramocaine-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing neomycin and polymyxin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Polymyxin B- and trimethoprim-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing bacitracin and polymyxin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing polymyxin B in ophthalmic dosage form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing polymyxin B in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing polymyxin B in topical dosage form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing polymyxin B in otic dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing polymyxin B in vaginal dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Allergy to polymyxin B	Causative agent (attribute)	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Polymyxin B sulfate (substance)	Is modification of (attribute)	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing neomycin and polymyxin B and prednisolone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Dexamethasone- and neomycin- and polymyxin B-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing bacitracin and neomycin and polymyxin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing bacitracin and hydrocortisone and neomycin and polymyxin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing hydrocortisone and neomycin and polymyxin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing polymyxin B in ocular dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing polymyxin B in cutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Bacitracin and neomycin and polymyxin B only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only bacitracin and neomycin and polymyxin B and pramocaine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only bacitracin and polymyxin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only bacitracin and hydrocortisone and neomycin and polymyxin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Dexamethasone and neomycin and polymyxin B only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only neomycin and polymyxin B and pramocaine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Neomycin and polymyxin B and prednisolone only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hydrocortisone and neomycin and polymyxin B only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only neomycin and polymyxin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only lidocaine and neomycin and polymyxin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only polymyxin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only polymyxin B and trimethoprim (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Polymyxin B only product in cutaneous dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Polymyxin B only product in ocular dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Polymyxin B only product in otic dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Polymyxin B only product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only polymyxin B in vaginal dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Polymyxin B (as polymyxin B sulfate) 500000 unit powder for solution for injection vial	Has basis of strength substance (attribute)	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Dexamethasone and neomycin and polymyxin B only product in ocular dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely dexamethasone 1 milligram/1 milliliter and neomycin (as neomycin sulfate) 3500 unit/1 milliliter and polymyxin B sulfate 6000 unit/1 milliliter conventional release suspension for eye drops (clinical drug)	Has precise active ingredient	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely dexamethasone 1 milligram/1 milliliter and neomycin (as neomycin sulfate) 3500 unit/1 milliliter and polymyxin B sulfate 6000 unit/1 milliliter conventional release suspension for eye drops (clinical drug)	Has basis of strength substance (attribute)	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing dexamethasone and neomycin and polymyxin B in ocular dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B	Inferred relationship	Existential restriction modifier (core metadata concept)	2

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1198119018	Polymyxin B (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1211344017	Polymyxin B	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1198119018	Polymyxin B (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1211344017	Polymyxin B	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
370901000195112	polimixina B	it	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
310011000077116	polymyxine B	fr	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
310011000077116	polymyxine B	fr	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
370901000195112	polimixina B	it	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module